These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 12634464

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.
    Small EJ, Smith MR, Seaman JJ, Petrone S, Kowalski MO.
    J Clin Oncol; 2003 Dec 01; 21(23):4277-84. PubMed ID: 14581438
    [Abstract] [Full Text] [Related]

  • 25. Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer.
    Sartor O, Reid RH, Hoskin PJ, Quick DP, Ell PJ, Coleman RE, Kotler JA, Freeman LM, Olivier P, Quadramet 424Sm10/11 Study Group.
    Urology; 2004 May 01; 63(5):940-5. PubMed ID: 15134985
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The role of disodium pamidronate in the management of bone pain due to malignancy.
    Groff L, Zecca E, De Conno F, Brunelli C, Boffi R, Panzeri C, Cazzaniga M, Ripamonti C.
    Palliat Med; 2001 Jul 01; 15(4):297-307. PubMed ID: 12054147
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Targeted radiotherapy with Sm-153-EDTMP in nine cases of canine primary bone tumours.
    Milner RJ, Dormehl I, Louw WK, Croft S.
    J S Afr Vet Assoc; 1998 Mar 01; 69(1):12-7. PubMed ID: 9646255
    [Abstract] [Full Text] [Related]

  • 31. Clinical role of Sm-153 EDTMP in the treatment of painful bone metastatic disease.
    Coronado M, Redondo A, Coya J, Espinosa E, Couto RM, Zamora P, Marin MD, Castelo B, Lillo ME, Frutos L, Barón MG, Curto LM.
    Clin Nucl Med; 2006 Oct 01; 31(10):605-10. PubMed ID: 16985364
    [Abstract] [Full Text] [Related]

  • 32. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
    Jiang CY, Zhu BL, Zhang YJ.
    Zhonghua Zhong Liu Za Zhi; 1994 Mar 01; 16(2):118-21. PubMed ID: 7523052
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Samarium-153 EDTMP therapy of disseminated skeletal metastasis.
    Turner JH, Martindale AA, Sorby P, Hetherington EL, Fleay RF, Hoffman RF, Claringbold PG.
    Eur J Nucl Med; 1989 Mar 01; 15(12):784-95. PubMed ID: 2483138
    [Abstract] [Full Text] [Related]

  • 35. [Evaluation of efficacy of 153Sm-EDTMP in patients with painful bone metastases of breast cancer].
    Wu H, Tan T, Fang L, Zhang X.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct 01; 34(4):716-8. PubMed ID: 14619591
    [Abstract] [Full Text] [Related]

  • 36. 177Lu/153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Cocktail: A Novel Palliative Treatment for Patients with Bone Metastases.
    Alavi M, Khajeh-Rahimi F, Yousefnia H, Mohammadianpanah M, Zolghadri S, Bahrami-Samani A, Ghannadi-Maragheh M.
    Cancer Biother Radiopharm; 2019 Jun 01; 34(5):280-287. PubMed ID: 30977670
    [Abstract] [Full Text] [Related]

  • 37. Background, reasons and benefits using the vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP.
    Sinzinger H, Weiss K, Hiltunen J.
    Anticancer Res; 2009 Aug 01; 29(8):3393-5. PubMed ID: 19661362
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.